APRI is back on due to the FDA approval anticipation, along with a strong bottom in the $1.10-$1.25 range. Any positive FDA news should send this back above $2
Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. Still has potential if the FDA approves Vitaros in the US on the November 17th meeting.
Amedica creates, manufactures and sells a broad range of silicon nitride ceramic products. Amedica is currently bouncing back after a negative meeting with the FDA. Now in the process of getting it re-submitted gives investors an opportunity to get in before the next PR.
1/11/17 AMDA hit a high of .73, sold 1/2.
1/18/17 AMDA kept trending lower under .66 so I was stopped out of my positions. After hours AMDA dropped to .49, this is why following your stops & listening to the market is key.
1/20/17 AMDA closed at .44
“With this submission, the goal is to introduce our proprietary CsC technology platform into the U.S. market without further delay,” said Dr. Bal.
Currently Amedica is holding up higher lows since .60 anything under .65 is a good entry. Be-careful on any breaks below .60. This company is known to do a lot of share offerings just beware.
About: Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the United States, Europe, and South America. The company offers Valeo silicon nitride spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; and a line of non-silicon nitride spinal surgery products for the treatment of deformity and degenerative spinal procedures. It also develops femoral heads for use in total hip replacements; and femoral condyle components for use in total knee replacements. The company markets and sells its products to surgeons and hospitals directly, as well as through a network of independent sales distributors. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah.